FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD
September 19th 2017Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read More
FDA Approves Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women
September 18th 2017The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g.
Read More
The Cost, Quality, and Experience Impact of Population Health in Primary Care
Read More